F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing

People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Sickle Cell Anemia Food and Drug Administration Drugs (Pharmaceuticals) Crispr (DNA) CRISPR Therapeutics Vertex Pharmaceuticals Inc Genetic Engineering Source Type: news